Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine

J Acquir Immune Defic Syndr. 1999 Sep 1;22(1):101-3. doi: 10.1097/00042560-199909010-00013.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Anti-HIV Agents / pharmacology
  • Anti-HIV Agents / therapeutic use*
  • Drug Resistance, Microbial / genetics
  • Drug Therapy, Combination
  • Genotype
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV-1* / classification
  • HIV-1* / drug effects
  • HIV-1* / genetics
  • Humans
  • Lamivudine / pharmacology
  • Lamivudine / therapeutic use*
  • Molecular Sequence Data
  • Phenotype
  • Prospective Studies
  • RNA, Viral / chemistry
  • Reverse Transcriptase Inhibitors / pharmacology
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Stavudine / pharmacology
  • Stavudine / therapeutic use*
  • Zidovudine / pharmacology
  • Zidovudine / therapeutic use*

Substances

  • Anti-HIV Agents
  • RNA, Viral
  • Reverse Transcriptase Inhibitors
  • Lamivudine
  • Zidovudine
  • Stavudine

Associated data

  • GENBANK/AF153369
  • GENBANK/AF153370
  • GENBANK/AF153371
  • GENBANK/AF153372
  • GENBANK/AF153373
  • GENBANK/AF153374
  • GENBANK/AF153375
  • GENBANK/AF153376
  • GENBANK/AF153377
  • GENBANK/AF153378
  • GENBANK/AF153379
  • GENBANK/AF153380
  • GENBANK/AF153381
  • GENBANK/AF153382
  • GENBANK/AF153383
  • GENBANK/AF153384
  • GENBANK/AF153385
  • GENBANK/AF153386
  • GENBANK/AF153387
  • GENBANK/AF153388
  • GENBANK/AF153389
  • GENBANK/AF153390
  • GENBANK/AF153391
  • GENBANK/AF153392
  • GENBANK/AF153393
  • GENBANK/AF153394
  • GENBANK/AF153395
  • GENBANK/AF153396
  • GENBANK/AF153397
  • GENBANK/AF153398